The active ingredient of NK012, SN-38, is metabolized by UGT1A enzymes, and polymorphisms of the UGT1A1 gene are known to be associated with an increased incidence of severe neutropenia [11]. The gene discussed is UGT1A1; the disease is neutropenia.